Related Experiment Videos
Minocycline sensitivity related to the phage type of multiply resistant staphylococci
Journal of Clinical Pathology
|June 1, 1975
Abstract:
Clinical isolated of multiply antibiotic-resistant strains of Staphlococcus aureus were divided into three groups by phage typing. The most prevalent type, which is usually cloxacillin resistant, was found to be moderately sensitive to minocycline. Unfortunately the degree of sensitivity is not sufficient to warrant the use of the antibiotic in severe staphlococcal infection.
Insights
Multiply antibiotic-resistant Staphylococcus aureus strains were studied. While moderately sensitive to minocycline, this antibiotic is not suitable for treating severe infections caused by these resistant bacteria.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Staphylococcus aureus is a significant pathogen, often exhibiting resistance to multiple antibiotics.
- The emergence of multiply antibiotic-resistant strains poses a challenge to effective treatment.
- Understanding the susceptibility patterns of these resistant strains is crucial for clinical management.
Purpose of the Study:
- To investigate the antibiotic susceptibility of multiply antibiotic-resistant Staphylococcus aureus clinical isolates.
- To evaluate the potential of minocycline as a treatment option for infections caused by specific strains of resistant Staphylococcus aureus.
Main Methods:
- Clinical isolates of multiply antibiotic-resistant Staphylococcus aureus were collected.
- Strains were categorized into three groups using phage typing.
- Antibiotic susceptibility testing was performed, with a focus on minocycline sensitivity.
Main Results:
- The most prevalent phage type of Staphylococcus aureus demonstrated cloxacillin resistance.
- This prevalent strain exhibited moderate sensitivity to minocycline.
- The observed level of minocycline sensitivity was insufficient for clinical use in severe staphylococcal infections.
Conclusions:
- Certain strains of multiply antibiotic-resistant Staphylococcus aureus remain susceptible to minocycline, albeit moderately.
- Minocycline is not recommended for treating severe infections caused by these resistant Staphylococcus aureus strains.
- Continued surveillance and research into effective treatments for antibiotic-resistant bacteria are necessary.